CMRXChimerix Inc

$0.00
$0.00
(0.00%)
Today
Updated:
Reported EarningsMar 21
Mkt Cap$801.08M
News
all
press releases
News Placeholder
Chimerix Stock Draws Heavy Retail Chatter After Landing Price-Target Hike On FDA Submission Plan For Cancer Drug
Following the news, JonesResearch raised its price target on Chimerix to $7 from $5 while maintaining a ‘Buy’ rating.
Stocktwits
News Placeholder
GeoVax, SIGA Jump After WHO Extends Mpox Public Emergency Status: Here’s What Retail Thinks
Emergent Biosolutions and Chimerix also saw marginal gains after the announcement.
Stocktwits
News Placeholder
These Three Stocks are Experiencing an Outbreak– Or a Breakout Depending How you Look at it
The monkeypox outbreak has boosted stocks of GeoVax Labs, Tonix Pharmaceuticals, and Chimerix. These companies are developing vaccines and treatments related to smallpox and viral diseases, positioning them as key players in addressing this health crisis.
Sponsored
<
...
1
>

Advertisement|Remove ads.